Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors: a Critical Review of the Literature

Samuel L. Washington; Gregory P. Murphy; Mohannad Awad; Thomas Gaither; Benjamin N. Breyer

doi:10.1007/s11884-017-0415-6

Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors: a Critical Review of the Literature

Samuel L. Washington, Gregory P. Murphy, Mohannad Awad, Thomas Gaither, Benjamin N. Breyer

Division of Urologic Surgery

Research output: Contribution to journal › Review article › peer-review

Abstract

Purpose of Review: Urinary diversion (UD) remains the last option for improving quality of life in patients with treatment-refractory urinary incontinence (UI) or voiding dysfunction after cancer treatment. We aim to critically review the utility of UD for UI and voiding dysfunction in patients previously treated for malignancy. Recent Findings: UD patients are at high risk given their oncologic treatment and multiple procedures prior to UD. The severe impact of UI and voiding dysfunction on quality of life is significant. Despite the risk of complications after UD, men reported significant improvement of their urinary symptoms and were confident that they would have sought UD sooner. Summary: UD remains a last option for some men dealing with severe urinary symptoms after treatment of pelvic malignancy in both men and women. Further investigation is needed to better characterize the burden of disease and potential gains surrounding management of these men.

Original language	English
Pages (from-to)	167-173
Number of pages	7
Journal	Current Bladder Dysfunction Reports
Volume	12
Issue number	2
DOIs	https://doi.org/10.1007/s11884-017-0415-6
State	Published - Jun 1 2017

Keywords

Cancer
Incontinence
Malignancy
Urinary diversion
Voiding dysfunction

Access to Document

10.1007/s11884-017-0415-6

Cite this

@article{aecc56e29b554eb1a09e659d014e223f,

title = "Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors: a Critical Review of the Literature",

abstract = "Purpose of Review: Urinary diversion (UD) remains the last option for improving quality of life in patients with treatment-refractory urinary incontinence (UI) or voiding dysfunction after cancer treatment. We aim to critically review the utility of UD for UI and voiding dysfunction in patients previously treated for malignancy. Recent Findings: UD patients are at high risk given their oncologic treatment and multiple procedures prior to UD. The severe impact of UI and voiding dysfunction on quality of life is significant. Despite the risk of complications after UD, men reported significant improvement of their urinary symptoms and were confident that they would have sought UD sooner. Summary: UD remains a last option for some men dealing with severe urinary symptoms after treatment of pelvic malignancy in both men and women. Further investigation is needed to better characterize the burden of disease and potential gains surrounding management of these men.",

keywords = "Cancer, Incontinence, Malignancy, Urinary diversion, Voiding dysfunction",

author = "Washington, {Samuel L.} and Murphy, {Gregory P.} and Mohannad Awad and Thomas Gaither and Breyer, {Benjamin N.}",

note = "Publisher Copyright: {\textcopyright} 2017, Springer Science+Business Media New York.",

year = "2017",

month = jun,

day = "1",

doi = "10.1007/s11884-017-0415-6",

language = "English",

volume = "12",

pages = "167--173",

journal = "Current Bladder Dysfunction Reports",

issn = "1931-7212",

number = "2",

}

TY - JOUR

T1 - Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors

T2 - a Critical Review of the Literature

AU - Washington, Samuel L.

AU - Murphy, Gregory P.

AU - Awad, Mohannad

AU - Gaither, Thomas

AU - Breyer, Benjamin N.

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose of Review: Urinary diversion (UD) remains the last option for improving quality of life in patients with treatment-refractory urinary incontinence (UI) or voiding dysfunction after cancer treatment. We aim to critically review the utility of UD for UI and voiding dysfunction in patients previously treated for malignancy. Recent Findings: UD patients are at high risk given their oncologic treatment and multiple procedures prior to UD. The severe impact of UI and voiding dysfunction on quality of life is significant. Despite the risk of complications after UD, men reported significant improvement of their urinary symptoms and were confident that they would have sought UD sooner. Summary: UD remains a last option for some men dealing with severe urinary symptoms after treatment of pelvic malignancy in both men and women. Further investigation is needed to better characterize the burden of disease and potential gains surrounding management of these men.

AB - Purpose of Review: Urinary diversion (UD) remains the last option for improving quality of life in patients with treatment-refractory urinary incontinence (UI) or voiding dysfunction after cancer treatment. We aim to critically review the utility of UD for UI and voiding dysfunction in patients previously treated for malignancy. Recent Findings: UD patients are at high risk given their oncologic treatment and multiple procedures prior to UD. The severe impact of UI and voiding dysfunction on quality of life is significant. Despite the risk of complications after UD, men reported significant improvement of their urinary symptoms and were confident that they would have sought UD sooner. Summary: UD remains a last option for some men dealing with severe urinary symptoms after treatment of pelvic malignancy in both men and women. Further investigation is needed to better characterize the burden of disease and potential gains surrounding management of these men.

KW - Cancer

KW - Incontinence

KW - Malignancy

KW - Urinary diversion

KW - Voiding dysfunction

UR - http://www.scopus.com/inward/record.url?scp=85019690391&partnerID=8YFLogxK

U2 - 10.1007/s11884-017-0415-6

DO - 10.1007/s11884-017-0415-6

M3 - Review article

AN - SCOPUS:85019690391

SN - 1931-7212

VL - 12

SP - 167

EP - 173

JO - Current Bladder Dysfunction Reports

JF - Current Bladder Dysfunction Reports

IS - 2

ER -

Urinary Diversion for Incontinence and Voiding Dysfunction in Cancer Survivors: a Critical Review of the Literature

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this